Monoclonal antibodies to influenza H1N1 virus uses thereof
AssigneesVanderbilt University, Icahn School of Medicine at Mount Sinai
InventorsJames E. Crowe, Christopher F. Basler
Life of this patent
Estimating the term…
Abstract
The present invention is directed to particular monoclonal antibodies and fragments thereof that find use in the detection, prevention and treatment of influenza virus infections. In particular, these antibodies may neutralize or limit the replication of H1N1 influenza virus. Also disclosed are improved methods for producing such monoclonal antibodies.
Claims6
An expression vector comprising a nucleic acid molecule encoding a heavy chain variable region comprising the sequence of SEQ ID NO:
- 7.
An expression vector comprising a nucleic acid molecule encoding a light chain variable region comprising the sequence of SEQ ID NO:
- 8.
An isolated antibody or antigen binding fragment thereof comprising the heavy chain of SEQ ID NO:
- 7 and the light chain of SEQ ID NO:
- 8, wherein the antibody or antigen binding fragment thereof is conjugated to a heterologous agent selected from the group consisting of:
- diagnostic agent, therapeutic agent, and an effector molecule.
Dependencies are inferred from the claim text.